Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

AFM-30a

From Wikipedia, the free encyclopedia

AFM-30a
Identifiers
  • N-[(1S)-4-[(1-amino-2-fluoroethylidene)amino]-1-(1-methylbenzimidazol-2-yl)butyl]-3-oxo-1,2-dihydroisoindole-4-carboxamide
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC23H25FN6O2
Molar mass436.491 g·mol−1
3D model (JSmol)
  • CN1C2=CC=CC=C2N=C1[C@H](CCCN=C(CF)N)NC(=O)C3=CC=CC4=C3C(=O)NC4
  • InChI=1S/C23H25FN6O2/c1-30-18-10-3-2-8-16(18)28-21(30)17(9-5-11-26-19(25)12-24)29-22(31)15-7-4-6-14-13-27-23(32)20(14)15/h2-4,6-8,10,17H,5,9,11-13H2,1H3,(H2,25,26)(H,27,32)(H,29,31)/t17-/m0/s1
  • Key:CHPVRACBRZIQQU-KRWDZBQOSA-N

AFM-30a is an experimental drug which was the first selective inhibitor to be developed of the enzyme peptidylarginine deiminase 2 (PAD2). It has been used to investigate the role of PAD2 in various inflammatory conditions and development of cancers. It was found to be active against pulmonary fibrosis in a mouse model.[1][2][3][4][5]

See also

[edit]

References

[edit]
  1. Muth A, Subramanian V, Beaumont E, Nagar M, Kerry P, McEwan P, et al. (April 2017). "Development of a Selective Inhibitor of Protein Arginine Deiminase 2". Journal of Medicinal Chemistry. 60 (7): 3198–3211. doi:10.1021/acs.jmedchem.7b00274. PMC 5477668. PMID 28328217.
  2. Martín Monreal MT, Rebak AS, Massarenti L, Mondal S, Šenolt L, Ødum N, et al. (2021). "Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4". Frontiers in Immunology. 12 716250. doi:10.3389/fimmu.2021.716250. PMC 8560728. PMID 34737738.
  3. Mansouri P, Mansouri P, Behmard E, Najafipour S, Kouhpayeh SA, Farjadfar A (October 2024). "Peptidylarginine deiminase (PAD): A promising target for chronic diseases treatment". International Journal of Biological Macromolecules. 278 (Pt 3) 134576. doi:10.1016/j.ijbiomac.2024.134576. PMID 39127273.
  4. Baird R, Yusuf A, Forde L, Pohl K, Kavanagh K, Fitzpatrick F, et al. (2024). "The vacuolar anti-Pseudomonal activity of neutrophil primary granule peptidyl-arginine deiminase enzymes". Frontiers in Immunology. 15 1452393. doi:10.3389/fimmu.2024.1452393. PMC 11527647. PMID 39493757.
  5. Zhang YM, Jin FY, Gao XM, Xu H, Zhu Y, Mao N (January 2025). "[The effects and mechanisms of PAD2 inhibitor AFM-30a attenuates pulmonary fibrosis in silicotic mice]". Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi = Zhonghua Laodong Weisheng Zhiyebing Zazhi = Chinese Journal of Industrial Hygiene and Occupational Diseases. 43 (1): 1–13. doi:10.3760/cma.j.cn121094-20240102-00001. PMID 39909591.